Bifidobacterium lactis Probio-M8 Adjuvant Treatment Confers Added Benefits to Patients with Coronary Artery Disease via Target Modulation of the Gut-Heart/-Brain Axes

Bifidobacterium lactis Probio-M8 Adjuvant Treatment Confers Added Benefits to Patients with Coronary Artery Disease via Target Modulation of the Gut-Heart/-Brain Axes

ABSTRACT Accumulating evidence suggests that gut dysbiosis may play a role in cardiovascular problems like coronary artery disease (CAD). Thus, target steering the gut microbiota/metabolome via probiotic administration could be a promising way to protect against CAD. A 6-month randomized, double-bli...

Full description

Bibliographic Details
Main Authors: Baoqing Sun, Teng Ma, Yalin Li, Ni Yang, Bohai Li, Xinfu Zhou, Shuai Guo, Shukun Zhang, Lai-Yu Kwok, Zhihong Sun, Heping Zhang
Format: Article
Language:English
Published: American Society for Microbiology 2022-04-01
Series:mSystems
Subjects:
Coronary artery disease
Bifidobacterium lactis Probio-M8
species-level genome bins (SGBs)
metabolomics
gut-heart axis
gut-brain axis
Online Access:https://journals.asm.org/doi/10.1128/msystems.00100-22

Internet

https://journals.asm.org/doi/10.1128/msystems.00100-22

Similar Items